Article

AMD program generates eye disease awareness

Prevent Blindness America (PBA) along with its affiliates and partners is joining forces to promote a national “AMD: Awareness Makes a Difference” program to educate adults on the disease and the steps that can be taken, including regular eye exams, to protect their vision.

Chicago-Prevent Blindness America (PBA) along with its affiliates and partners is joining forces to promote a national “AMD: Awareness Makes a Difference” program to educate adults on the disease and the steps that can be taken, including regular eye exams, to protect their vision.

Starting this week, PBA is offering a free magnetic Amsler grid that individuals can use to monitor their central vision. If the lines appear wavy, distorted, or missing, it may be a sign of eye disease, such as AMD. Potential patients will be encouraged to make an appointment with an ophthalmologist immediately.

“AMD is the leading cause of blindness in Americans ages 50 and older,” said Hugh R. Parry, president and chief executive officer of PBA. “By providing those in our community with the information they need about risk factors, symptoms, and treatment options, our goal is to help keep the eyes healthy well into the future.”

For more information, visit the PBA website at preventblindness.org/amd or call 800/331-2020.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) CCOI's new CEO Malvina Eydelman, MD, outlines her mission and vision for the organization
CIME 2025: Neda Shamie, MD, on expanding options in pharmacological presbyopia management
At CIME 2025, Neda Shamie, MD, answers questions about Demodex blepharitis
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
© 2025 MJH Life Sciences

All rights reserved.